Security key
670002104
- Security type / class
- Equity / COM
- Total 13F shares
- 156,744,426
- Total 13F value
- $294,684,409
- Share change
- -5,786,883
- Put/Call ratio
- 106%
- SEC-reported price per share
- $1.88
- Number of holders
- 155
- Value change
- -$5,948,676
- Number of buys
- 55
- Number of sells
- 61
Open additional details 1 more signal available
Report period
Q3 2018
Institutions
155
Top holders
10
NVAX full security history
Ownership snapshot
Full 13F holder table
NOVAVAX INC SEC filings
NOVAVAX INC company facts
Broader feeds
Ownership snapshot
Top reported holders of NVAX - NOVAVAX INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2018
13F
Highest disclosed value: $41,340,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. has the largest disclosed position value at $41.34M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value
Top 5
BlackRock Finance, Inc.
$41.34M
STATE STREET CORP
$31.23M
VANGUARD GROUP INC
$28.19M
BB BIOTECH AG
$11.16M
MORGAN STANLEY
$8.41M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$41,340,000
30,851,113 shares
|
— | 30 Jun 2018 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$31,230,000
23,307,696 shares
|
— | 30 Jun 2018 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$28,193,000
21,039,811 shares
|
— | 30 Jun 2018 |
| BB BIOTECH AG |
13F
Company
|
—
denominator unverified
|
$11,162,000
8,330,000 shares
|
— | 30 Jun 2018 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$8,406,000
6,272,373 shares
|
— | 30 Jun 2018 |
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$7,654,000
5,711,765 shares
|
— | 30 Jun 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
155
Shares
156,744,426
Rows available
155
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
145
Q3 2018 holders
155
Holder diff
10
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 value | Q3 2018 value | Value change | Value Chg % |
|---|